NORGES BANK

Q3 2024 13F Holdings Report, Stock Holdings

Signature - Title
Stanislav Boiadjiev - Lead Regulatory Compliance Advisor
Location
Oslo, Norway
Holdings as of
30 Sep 2024
Value $
$715,892,335,491
Num holdings
1,839
Filing time
13 Nov 2024, 08:46:19 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MSFT, AAPL, NVDA, AMZN, and GOOGL. Confidential Treatment Requested (one or more holding(s) omitted).
Previous filing
Q2 2024 - 14 Aug 2024
Next filing
Q4 2024 - 12 Feb 2025
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q3 compared to 2024 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Stanislav Boiadjiev Lead Regulatory Compliance Advisor Oslo, Norway 13 Nov 2024

Norges Bank has submitted its Form 13F to the Securities and Exchange Commission pursuant to a request for confidential treatment. This action is consistent with discussions between Norges Bank and the Staff of the Securities and Exchange Commission to coordinate the reporting required under Section 13(f) with the extensive public disclosure requirements under Norwegian law applying to Norges Bank. Collateral received through secured lending and borrowing transactions in the form of securities, where Norges Bank has the right to sell or pledge the security, is not recognized in its balance sheet unless reinvested. Correspondingly, such collateral is not reflected in our 13F reporting.